Profound Medical (PROF) Invested Capital (2018 - 2026)

Profound Medical's Invested Capital history runs 9 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 417.16% increase from a year earlier, with the FY2024 full-year figure at $1.7 million, up 107.53% from the prior year.
• Invested Capital improved to $4.5 million in Q1 2026 per PROF's latest filing, from $4.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $7.2 million in Q4 2022 and bottomed at $837000.0 in Q4 2023.
• The 5-year median for Invested Capital is $4.5 million (2025), against an average of $3.7 million.
• Across the five-year window, Invested Capital soared 420.99% in 2022 and plunged 88.33% in 2023, its largest moves.
• Year by year, Invested Capital stood at $7.2 million in 2022, then plunged by 88.33% to $837000.0 in 2023, then surged by 107.53% to $1.7 million in 2024, then soared by 157.92% to $4.5 million in 2025, then increased by 0.51% to $4.5 million in 2026.
• Per Business Quant, the three latest PROF Invested Capital figures stand at $4.5 million (Q1 2026), $4.5 million (Q3 2025), and $1.7 million (Q4 2024).